MapHospitals
Instituto Jalisciense de Cancerologia

Instituto Jalisciense de Cance...

Guadalajara
VS
Neurological Diseases Institute of Castilla-La Mancha

Neurological Diseases Institut...

Guadalajara
Feature Instituto Jalisciense de Can... Neurological Diseases Instit...
Verified No No
Rating
(0 reviews)
(0 reviews)
City Guadalajara Guadalajara
Address Coronel Calderón 715, El Retiro, 44200 Guadalajara, Jal., Mexico P.º Estación, 2, 19001 Guadalajara, Spain
Enquiries 0 0
Phone +52 33 3658 004 +34 949 21 15 0
Specialities Count 2 3
Website Not listed Visit
Specialities
Oncology Otorhinolaryngology
Neurology Otorhinolaryngology Urology

Shared (1)

Otorhinolaryngology

Only at Instituto Jalisciense de...

Oncology

Only at Neurological Diseases Ins...

Neurology Urology

Instituto Jalisciense de Cancerologia vs Neurological Diseases Institute of Castilla-La Mancha: Detailed Comparison

Choosing the right hospital is a critical decision for patients seeking quality healthcare. Instituto Jalisciense de Cancerologia, located in Guadalajara, offers 2 medical specialities . Meanwhile, Neurological Diseases Institute of Castilla-La Mancha in Guadalajara provides 3 specialities .

Both hospitals share 1 common speciality, including Otorhinolaryngology. This means patients looking for Otorhinolaryngology can consider either hospital based on location, reviews, and other preferences.

Instituto Jalisciense de Cancerologia uniquely offers Oncology. Neurological Diseases Institute of Castilla-La Mancha stands out with Neurology, Urology.

For detailed information, visit the individual hospital pages: Instituto Jalisciense de Cancerologia or Neurological Diseases Institute of Castilla-La Mancha. You can also use our hospital comparison tool to compare up to 3 hospitals side by side.

Get Free Consultation

We'll connect you with the right hospital

Your Details Treatment Info

Secure Reply in 24h No spam
hospital(s) selected
Compare Now
We use cookies and analytics to improve your experience. By continuing to browse, you consent to our use of cookies. Privacy Policy